We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Eco Animal Health Group plc (EAH) Ordinary 5p

Sell:67.00p Buy:75.00p 0 Change: No change
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:67.00p
Buy:75.00p
Change: No change
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:67.00p
Buy:75.00p
Change: No change
Market closed Prices as at close on 20 December 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

ECO Animal Health Group plc is a United Kingdom-based animal health biotechnology company. The Company is engaged in the manufacturing and supplying of animal health products globally. The Company is focused on providing solutions to respiratory and enteric diseases in pigs and poultry. It provides quality products for swine and poultry, primarily anti-infectives. The Company’s segment includes the United Kingdom, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World. The Company research, develops and commercializes products for livestock. The Company’s lead product, Aivlosin, is an antimicrobial which is used under veterinary prescription for the treatment of economically important respiratory and gastrointestinal diseases in pigs and poultry. The Company is also engaged in researching and developing new solutions to enhance the lives of pigs and poultry.

Contact details

Address:
78 Coombe Road
NEW MALDEN
KT3 4QS
United Kingdom
Telephone:
+44 (020) 83362900
Website:
https://www.ecoanimalhealthgroupplc.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 28 November 2024 28/11/24
AGM 26 September 2024 26/09/24
Annual report 16 August 2024 16/08/24
Final results 15 July 2024 15/07/24
Trading Announcement 15 July 2024 15/07/24
Trading Announcement 25 April 2024 25/04/24
Trading Announcement 21 March 2024 21/03/24
General meeting 19 March 2024 19/03/24

General stock information

EPIC:
EAH
ISIN:
GB0032036807
Market cap:
£48.11 million
Shares in issue:
67.76 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • David Hallas
    Chief Executive Officer, Executive Director
  • Christopher John Wilks
    Chief Financial Officer, Executive Director, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.